Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Einav, Zeevi"'
Autor:
Tali Voloshin, Mijal Munster, Yuval Shmueli, Uri Weinberg, Adi Haber, Anna Shteingauz, Helena Mumblat, Shiri Davidi, Shiri Danilov, Moshe Giladi, Einav Zeevi, Yoram Palti, Antonia Martinez-Conde, Adrian Kinzel, Catherine Tempel-Brami, Yaara Porat, Eyal Dor-On, Ori Braten, Carolina Lajterer, Rosa S. Schneiderman, Roni Blatt
Publikováno v:
Lung Cancer. 160:99-110
Objectives Tumor Treating Fields (TTFields) are low intensity, intermediate frequency, alternating electric fields with antimitotic effects on cancerous cells. TTFields concomitant with pemetrexed and a platinum agent are approved in the US and EU as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4f4ed745c65ea1f000e412d10635e98
https://doi.org/10.1016/j.lungcan.2021.08.011
https://doi.org/10.1016/j.lungcan.2021.08.011
Autor:
Roni Frechtel-Gerzi, Daria Gerasimova, Einav Zeevi, Inbar Schlachet-Drukerman, Helena Mumblat, Antonia Martinez-Conde, Eyal Dor-On, Itai Tzchori, Adi Haber, Moshe Giladi, Uri Weinberg, Yoram Palti, Greg Palmer, Angeles A. Secord
Publikováno v:
Cancer Research. 83:2666-2666
Introduction: Cervical cancer is a serious health problem despite the fact it is highly preventable. Early-stage cervical cancer treatment often involves surgery; however advanced, recurrent, or metastatic cases require systemic therapy. Chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2174c12bc8517a9ba286949a576f8f9f
https://doi.org/10.1158/1538-7445.am2023-2666
https://doi.org/10.1158/1538-7445.am2023-2666
Autor:
Naama Flint-Brodsly, Einav Zeevi, Kerem Wainer-Katsir, Hila Fishman, Antonia Martinez-Conde, Eyal Dor-On, Mijal Munster, Yaara Porat, Tali Voloshin, Shiri Davidi, Adi Haber, Moshe Giladi, Uri Weinberg, Yoram Palti
Publikováno v:
Cancer Research. 83:2723-2723
Background: Gastric cancer, one of the most common types of cancers, is mainly treated with the FOLFOX chemotherapy regimen (oxaliplatin, fluorouracil [5-FU], and leucovorin); yet long-term survival remains poor. Tumor Treating Fields (TTFields) are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::907be962c4794c68ccb1d4d8e41e9b24
https://doi.org/10.1158/1538-7445.am2023-2723
https://doi.org/10.1158/1538-7445.am2023-2723
Autor:
Shay Cahal, Yaara Porat, Moshe Giladi, Eilon D. Kirson, A. Shteingauz, Adrian Kinzel, Aviran Itzhaki, Einav Zeevi, Uri Weinberg, Tali Voloshin, Yoram Palti, Catherine Tempel Brami, Mijal Munster, Noa Kaynan, Shiri Davidi, Rosa S. Schneiderman, Roni Blat
Publikováno v:
Cancer Immunology, Immunotherapy
Tumor-treating fields (TTFields) are alternating electric fields in a specific frequency range (100–300 kHz) delivered to the human body through transducer arrays. In this study, we evaluated whether TTFields-mediated cell death can elicit antitumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9715fe0f2ba8490d0c2aedea5d2f136b
https://doi.org/10.1007/s00262-020-02534-7
https://doi.org/10.1007/s00262-020-02534-7
Autor:
Shiri, Davidi, Sara, Jacobovitch, Anna, Shteingauz, Antonia, Martinez-Conde, Ori, Braten, Catherine, Tempel-Brami, Einav, Zeevi, Roni, Frechtel-Gerzi, Hila, Ene, Eyal, Dor-On, Tali, Voloshin, Itai, Tzchori, Adi, Haber, Moshe, Giladi, Adrian, Kinzel, Uri, Weinberg, Yoram, Palti
Publikováno v:
Cancers. 14(12)
Hepatocellular carcinoma (HCC), a highly aggressive liver cancer, is a leading cause of cancer-related death. Tumor Treating Fields (TTFields) are electric fields that exert antimitotic effects on cancerous cells. The aims of the current research wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d1063f80ee7db0da289ded88759dd9d5
https://pubmed.ncbi.nlm.nih.gov/35740624
https://pubmed.ncbi.nlm.nih.gov/35740624
Autor:
Shiri Davidi, Sara Jacobovitch, Anna Shteingauz, Antonia Martinez-Conde, Ori Braten, Catherine Tempel-Brami, Einav Zeevi, Roni Frechtel-Gerzi, Hila Ene, Eyal Dor-On, Tali Voloshin, Itai Tzchori, Adi Haber, Moshe Giladi, Adrian Kinzel, Uri Weinberg, Yoram Palti
Publikováno v:
Cancers. 15:1182
The authors wish to make minor corrections to Figure 1 and Figure 2 of the following paper [...]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b03a11d50bbc77c6f02e6e2ffa93496
https://doi.org/10.3390/cancers15041182
https://doi.org/10.3390/cancers15041182
Autor:
Shiri Davidi, Sara Jacobovitch, Anna Shteingauz, Antonia Martinez-Conde, Ori Braten, Catherine Tempel-Brami, Einav Zeevi, Roni Frechtel-Gerzi, Hila Ene, Eyal Dor-On, Tali Voloshin, Itai Tzchori, Adi Haber, Moshe Giladi, Adrian Kinzel, Uri Weinberg, Yoram Palti
Publikováno v:
Cancers; Volume 14; Issue 12; Pages: 2959
Hepatocellular carcinoma (HCC), a highly aggressive liver cancer, is a leading cause of cancer-related death. Tumor Treating Fields (TTFields) are electric fields that exert antimitotic effects on cancerous cells. The aims of the current research wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f49ebff0f871eb7e255888adc2075a4e
https://doi.org/10.3390/cancers14122959
https://doi.org/10.3390/cancers14122959
Autor:
Tali Voloshin, A. Shteingauz, Mijal Munster, A. Haber, Uri Weinberg, Karnit Gotlib, S. Jacobovitch, Yoram Palti, Shiri Davidi, Adrian Kinzel, E. Dor-On, Einav Zeevi, Rosa S. Schneiderman, C. Tempel Brami, Moshe Giladi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e47-e48
Purpose/Objective(s) Hepatocellular carcinoma (HCC) is a highly malignant liver cancer and is one of the leading causes of cancer-related mortality worldwide. Sorafenib, a multikinase inhibitor, is the main first-line treatment for advanced HCC, yet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48d2dda638cc4d9fe781df48eff58cf7
https://doi.org/10.1016/j.ijrobp.2021.07.378
https://doi.org/10.1016/j.ijrobp.2021.07.378
Autor:
A. Martinez-Conde, A. Haber, S. Danilov, Uri Weinberg, C. Lajterer, C. Tempel-Brami, Y. Shmueli, Yaara Porat, Rosa S. Schneiderman, O. Braten, Yoram Palti, A. Shteingauz, R. Blatt, Shiri Davidi, Moshe Giladi, H. Mumblat, E. Dor-On, Einav Zeevi, Tali Voloshin, Adrian Kinzel, Mijal Munster
Publikováno v:
Journal of Thoracic Oncology. 16:S956-S957
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4556b76594f03bec61512c101b541a87
https://doi.org/10.1016/j.jtho.2021.08.229
https://doi.org/10.1016/j.jtho.2021.08.229
Autor:
Moshe Giladi, E. Dor-On, Einav Zeevi, Mijal Munster, Rosa S. Schneiderman, A. Shteingauz, C. Tempel-Brami, T. Voloshin, A. Haber, S. Jacobovitch, Shiri Davidi
Publikováno v:
Annals of Oncology. 32:S162-S163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1937521bbb7f426a4d60748843da4195
https://doi.org/10.1016/j.annonc.2021.05.239
https://doi.org/10.1016/j.annonc.2021.05.239